Question: say JT is right and generics won't have API available to meet demand, not even close - what do insurers do when a generic exists but it's not in stock and won't be for a long time? Do they refuse to pay for V at all, or have it at T4, expensive as hell w/o the coupon? Another thing - does this outcome change what insurers were going to do for 2021, elevate V to T3?
If GV supply really is limited, generics will only provide it to the largest and most lucrative markets, meaning NYC and LA - what happens to everyone in between where GV isn't available?
News 
Market Data 
Discover 
